Effect of Kinetic Control Training on Flexion Relaxation Phenomenon and Craniovertebral Angle in Cervical Radiculopathy Patients
Launched by CAIRO UNIVERSITY · Dec 10, 2024
Trial Information
Current as of May 03, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a type of exercise called kinetic control training to see how it affects certain problems in patients with cervical radiculopathy, a condition that causes pain and discomfort in the neck and arms due to issues in the spine. Specifically, the researchers want to understand how this training influences the "flexion relaxation phenomenon" and the craniovertebral angle, which can indicate neck posture and alignment.
To be eligible for the study, participants need to be between 40 and 55 years old and have been diagnosed with cervical spondylosis, experiencing symptoms for more than three months. They should also have a specific type of nerve pain in one arm due to changes in their lower neck. However, individuals with certain medical conditions, like spinal canal narrowing or rheumatoid arthritis, will not be included. Those who take part can expect to engage in training aimed at improving their neck function and posture, which may help alleviate their symptoms. The trial is currently not recruiting participants, so it's a future opportunity for those who fit the criteria.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Patients will be referred from neurologist with the diagnosis cervical spondylosis.
- • 2. Patients will be included if they have unilateral radiculopathy due to spondylotic changes of the lower cervical spine (C5-C6 and C6-C7).
- • 3. Duration of symptoms is more than three months to avoid acute stage of inflammation.
- • 4. Patient's age ranged from 40 to 55 years.
- • 5. Patients from both sexes.
- • 6. Body mass index of all patients is ranged from 25-30 kg/m2.
- • 7. Patients will be screened prior to inclusion by measuring the craniovertebral angle, if the angle was less than 50, then a participant will be referred to the study
- Exclusion Criteria:
- • 1. Spinal canal stenosis.
- • 2. Rheumatoid arthritis.
- • 3. Vertebrobasilar insufficiency.
- • 4. Spinal instability due to structural cause e.g., spondylolisthesis.
- • 5. Systemic disease (cardiovascular, infectious and/or metabolic disease that could interrupt exercises).
- • 6. Spinal tumors.
About Cairo University
Cairo University, a premier institution in Egypt, is dedicated to advancing medical research and education through innovative clinical trials. With a strong emphasis on improving healthcare outcomes, the university collaborates with various stakeholders to conduct rigorous scientific studies that address critical health challenges. Leveraging its extensive resources and expert faculty, Cairo University aims to contribute valuable insights to the medical community and enhance patient care both locally and globally. Through its commitment to ethical research practices and excellence, the university plays a pivotal role in shaping the future of healthcare in the region.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Giza, , Egypt
Patients applied
Trial Officials
Eman Samir Mohamed Fayez, PhD
Study Chair
Professor, Cairo university
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported